---
title: "Agilent Technologies, Inc. (A.US) Q1 2022 Earnings Call"
description: "Agilent Technologies is committed to providing application-focused solutions for the life sciences, diagnostics, and applied chemical markets. It operates throu"
locale: "en"
url: "https://longbridge.com/en/lives/13467"
parent: "https://longbridge.com/en/lives.md"
category: "Earnings Call"
---

# Agilent Technologies, Inc. (A.US) Q1 2022 Earnings Call

**Status**: Unknown
**Category**: Earnings Call

## Description

Agilent Technologies is committed to providing application-focused solutions for the life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software to identify, quantify, and analyze the physical and biological properties of substances and products, as well as clinical and life science research fields to query samples at the molecular and cellular level. The Diagnostics and Genomics segment includes activities to provide active drug ingredients for oligotherapy, as well as solutions including reagents, instruments, software, and consumables. The Agilent CrossLab segment includes start-up, operational, training and compliance support, software-as-a-service, as well as asset management and consulting services. The company was founded in May 1999 and is headquartered in Santa Clara, California.

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.